-
艾媒报告 |2019年中国小游戏产业研究与发展趋势分析报告
本报告研究涉及企业/品牌包括:白鹭科技、雅基软件、搜游网络、泡泡游戏、勇往科技、西米游戏、腾讯游戏、网易游戏、完美世界、金山逍遥、盛大游戏、空中网、世纪天成、畅游、巨人网络、蜗牛游戏、多玩游戏网、新浪游戏、游久网、太平洋游戏网
中国游戏市场繁荣发展,2018年其实际销售收入接近2150亿元,约占全球的27.48%。同时,随着微信等社交应用的高度普及,移动化、轻度化小程序游戏开始成为中国游戏产业的新动力。iiMedia Reserach(艾媒咨询)大数据监测显示,作为微信小程序的头部应用,小游戏数量超过7000个,日活用户数量达到1亿,人均日使用市场为13分钟。随着5G技术的发展和小游戏市场的成熟,其规模还将不断扩大。
revenue approaching 215 billion yuan in 2018, accounting for about 27.48% of the world's. At the same time, with the high popularity of social applications such as WeChat, Mobile, mildly small program games began to become the new driving force of China's gaming industry. Iimedia reserach (Media Consulting) Big data monitoring shows that as the head of WeChat program, the number of small games more than 7,000, the number of live users reached 100 million, the daily use of the market for 13 minutes. At present, the small game industry has explored a mature industrial chain, business model covers the prop shopping, advertising, e-commerce and other aspects. However, the small game industry as a whole there are weak stickiness, serious homogenization and low maturity of profit model problems. iiMedia Research monitoring found that the future of the small game industry has a number of development trends such as medium and heavy game entry market, advertising market expansion, 5G technology guidance form change and so on. -
艾媒报告 |2019全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:天猫医馆,七乐康,京卫大药房,阿里健康大药房,京东大药房,健客, 1药网,360好药,八百方,818医药网,CVS,Walgreens ,RiteAid ,开心人网上药店,药房网,药材买卖网,珍材网,中药材天地网,商康网,科欣医药,医药在线,我的医药网,药品交易网,药品终端网,药师帮,海王晨星,快方送药,药给力,搜药送,药急送,U医U药,叮当送药,健客网上药店,康爱多掌上药店,问药,好药师,111集团,中宏保险,医联,腾讯,仁和药业,浙江扁鹊,漱玉平民,华人健康,一树药业,德生堂
2019中国医药电商主要形成了B2C、B2B、O2O三种模式,B2C模式体量稳定在6%左右,规模呈增长趋势,预计2019年的市场交易额将达到554.6亿元;B2B模式下,西药类产品的需求比例较高,达87.1%,中药材、传统药品和第三方交易等都形成了专属B2B平台;而近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,但区域覆盖度和消费者的信任度需要提高。iiMedia Research(艾媒咨询)大数据监测显示,目前1药网、健客网上药店、康爱多掌上药店的的综合实力排行较强。
2019 China's pharmaceutical e-commerce mainly formed three modes of B2C, B2B and O2O. The volume of B2C model is stable at around 6%, and the scale is increasing. It is expected that the market transaction volume in 2019 will reach 55.46 billion yuan; in B2B mode, western medicine The demand ratio of products is relatively high, reaching 87.1%. Chinese herbal medicines, traditional medicines and third-party transactions have formed a proprietary B2B platform. In recent years, the O2O model has emerged mainly through “drainage-conversion-consumption-feedback”. Achieve profitability, but regional coverage and consumer trust need to be improved. iiMedia Research (Ai Media Consulting) big data monitoring shows that the current comprehensive strength of 1 drug network, Jianke online pharmacy, Kang Aiduo pharmacy is strong.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告